Zeus prides itself on manufacturing high-quality medical device componentry. Its latest solution enables patients and clinicians to avoid exposure to ionising radiation from X-rays.
For more than 50 years, Zeus has helped manufacturers around the world to produce extruded components that push boundaries in surgical fields. The company's latest advancement in this area is the LCP (liquid crystal polymer) monofilament, which provides superior performance as catheter reinforcement braiding and as a replacement for metal braiding, such as stainless steel. Catheters braided with LCP can be used in MRI, removing the need for X-ray visualisation, which exposes patients and clinicians to ionising radiation.
MRI was first introduced in the 1970s as a potential medical tool. Since then, MRI has become a household term, and an industry standard for medical diagnosis and treatment with regard to soft-tissue visualisation. However, procedures that require catheterisation still use X-ray to guide the catheter because of the metal catheter components, which are incompatible with MRI. These X-ray procedures expose patients and clinicians to ionising radiation.
In recent years, there has been renewed emphasis on eliminating the radiation component from catheter procedures. To meet this latest challenge, Zeus has developed an LCP monofilament fibre that is ideally suited for catheter braiding reinforcement to be used in catheter construction. This fibre contains no metal and is thus MRI-compatible; it also eliminates the need for radio-opaque contrast material or expensive platinum marker bands typically used in X-ray procedures.
Because minimally invasive procedures have become routine today, the potential applications for this LCP monofilament are broad. Many of the applications where catheters are employed would benefit from Zeus LCP fibre, ranging from diagnostic and therapeutic to investigational.
LCPs are thermoplastic resins that exhibit unique properties. However, these special plastics are often difficult to process and can be too cost-prohibitive to maximise end-user benefit. Zeus has perfected a process to produce LCP as a monofilament fibre with all of the significant properties of LCPs, such as exceptional mechanical strength, heat tolerance for autoclaving and chemical inertness.
As catheter reinforcement material, Zeus LCP monofilament rivals stainless steel on many fronts, including exceptional torque response, pushability and distal-end deflectability. The LCP fibre braiding can be used in lieu of metals such as stainless steel, nitinol and tungsten, which are typically used in catheter construction. Zeus LCP fibre possesses excellent tensile strength, is Class-VI approved and can be autoclaved.
During the catheter manufacturing process, the LCP monofilament is easily braided with industry-standard equipment and resists fraying ('bird nesting') for maximum production efficiency. Therefore, Zeus's LCP fibre easily integrates into your current braiding process with minimal changes. The LCP monofilament resists kinking and can be wound on to Steeger and Wardwell bobbins, and DIN 160 spools. Due to its wide working temperature range of -50 to +150°C, the LCP monofilament is autoclavable and Class-VI approved.
LCP can be challenging to obtain for medical device componentry due to regulatory paperwork. Zeus can streamline this work for you to get you to your goal sooner. The company can expedite your supply chain and has samples ready for evaluation. It has the capability to provide LCP monofilament in custom sizes and profiles. Regardless of your application, Zeus's LCP monofilament fibre is unmatched in terms of performance and value.